Good morning and welcome to this week’s Flight Path. Equities saw the “Go” trend continue…
Category:
Stock
-
-
Stock
Cardiol Therapeutics’ Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024
Marked and rapid reductions in both pericarditis pain and inflammation maintained throughout the 26-week study…
-
-
-
-
-
-
-
-